Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gap.

Abstract

Authors

• Charles R Marshall
  Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK; Neurology Department, Barts Health NHS Trust, London, UK. Electronic address: charles.marshall@qmul.ac.uk.
• Ijeoma Uchegbu
  Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK; Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, Queen Mary University of London, London, UK.

Keywords

External Resources